Abstract
Purpose
To elucidate additional substrate specificities of ALDH1B1 and determine the effect that human ALDH1B1 polymorphisms will have on substrate specificity.
Methods
Computational-based molecular modeling was used to predict the binding of the substrates propionaldehyde, 4-hydroxynonenal, nitroglycerin, and all-trans retinaldehyde to ALDH1B1. Based on positive in silico results, the capacity of purified human recombinant ALDH1B1 to metabolize nitroglycerin and all-trans retinaldehyde was explored. Additionally, metabolism of 4-HNE by ALDH1B1 was revisited. Databases queried to find human polymorphisms of ALDH1B1 identified three major variants: ALDH1B1*2 (A86V), ALDH1B1*3 (L107R), and ALDH1B1*5 (M253V). Computational modeling was used to predict the binding of substrates and of cofactor (NAD+) to the variants. These human polymorphisms were created and expressed in a bacterial system and specific activity was determined.
Results
ALDH1B1 metabolizes (and appears to be inhibited by) nitroglycerin and has favorable kinetics for the metabolism of all-trans retinaldehyde. ALDH1B1 metabolizes 4-HNE with higher apparent affinity than previously described, but with low throughput. Recombinant ALDH1B1*2 is catalytically inactive, whereas both ALDH1B1*3 and ALDH1B1*5 are catalytically active. Modeling indicated that the lack of activity in ALDH1B1*2 is likely due to poor NAD+ binding. Modeling also suggests that ALDH1B1*3 may be less able to metabolize all-trans retinaldehyde and that ALDH1B1*5 may bind NAD+ poorly.
Conclusions
ALDH1B1 metabolizes nitroglycerin and all-trans-retinaldehyde. One of the three human polymorphisms, ALDH1B1*2, is catalytically inactive, likely due to poor NAD+ binding. Expression of this variant may affect ALDH1B1-dependent metabolic functions in stem cells and ethanol metabolism.
Similar content being viewed by others
Abbreviations
- 1,2 DNG:
-
1,2 dinitroglycerin
- 1,3 DNG:
-
1,3 dinitroglycerin
- 4-HNE:
-
4-hydroxynonenal
References
Marchitti SA, Brocker C, Stagos D, Vasiliou V. Non-P450 aldehyde oxidizing enzymes: the aldehyde dehydrogenase superfamily. Expert Opin Drug Metab Toxicol. 2008;4(6):697–720.
Hsu LC, Chang WC. Cloning and characterization of a new functional human aldehyde dehydrogenase gene. J Biol Chem. 1991;266(19):12257–65.
Stewart MJ, Malek K, Xiao Q, Dipple KM, Crabb DW. The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme. Biochem Biophys Res Commun. 1995;211(1):144–51.
Stagos D, Chen Y, Brocker C, Donald E, Jackson BC, Orlicky DJ, et al. Aldehyde dehydrogenase 1B1: molecular cloning and characterization of a novel mitochondrial acetaldehyde-metabolizing enzyme. Drug Metab Dispos. 2010;38(10):1679–87.
Stagos D, Chen Y, Cantore M, Jester JV, Vasiliou V. Corneal aldehyde dehydrogenases: multiple functions and novel nuclear localization. Brain Res Bull. 2010;81(2–3):211–8.
Daiber A, Wenzel P, Oelze M, Schuhmacher S, Jansen T, Munzel T. Mitochondrial aldehyde dehydrogenase (ALDH-2)–maker of and marker for nitrate tolerance in response to nitroglycerin treatment. Chem Biol Interact. 2009;178(1–3):40–7.
Theodosiou M, Laudet V, Schubert M. From carrot to clinic: an overview of the retinoic acid signaling pathway. Cell Mol Life Sci. 2010;67(9):1423–45.
Crabb DW, Stewart MJ, Xiao Q. Hormonal and chemical influences on the expression of class 2 aldehyde dehydrogenases in rat H4IIEC3 and human HuH7 hepatoma cells. Alcohol Clin Exp Res. 1995;19(6):1414–9.
Luo P, Wang A, Payne KJ, Peng H, Wang JG, Parrish YK, et al. Intrinsic retinoic acid receptor alpha-cyclin-dependent kinase-activating kinase signaling involves coordination of the restricted proliferation and granulocytic differentiation of human hematopoietic stem cells. Stem Cells. 2007;25(10):2628–37.
Ioannou M, Serafimidis I, Arnes L, Sussel L, Singh S, Vasiliou V, et al. ALDH1B1 is a potential stem/progenitor marker for multiple pancreas progenitor pools. Dev Biol. 2013;374(1):153–63.
Chen Z, Foster MW, Zhang J, Mao L, Rockman HA, Kawamoto T, et al. An essential role for mitochondrial aldehyde dehydrogenase in nitroglycerin bioactivation. Proc Natl Acad Sci U S A. 2005;102(34):12159–64.
Zhang H, Chen YG, Xu F, Xue L, Jiang CX, Zhang Y. The relationship between aldehyde dehydrogenase-2 gene polymorphisms and efficacy of nitroglycerin. Zhonghua Nei Ke Za Zhi. 2007;46(8):629–32.
Beretta M, Sottler A, Schmidt K, Mayer B, Gorren AC. Partially irreversible inactivation of mitochondrial aldehyde dehydrogenase by nitroglycerin. J Biol Chem. 2008;283(45):30735–44.
Sherman D, Dave V, Hsu LC, Peters TJ, Yoshida A. Diverse polymorphism within a short coding region of the human aldehyde dehydrogenase-5 (ALDH5) gene. Hum Genet. 1993;92(5):477–80.
Sherman DI, Ward RJ, Yoshida A, Peters TJ. Alcohol and acetaldehyde dehydrogenase gene polymorphism and alcoholism. EXS. 1994;71:291–300.
Husemoen LL, Fenger M, Friedrich N, Tolstrup JS, Beenfeldt Fredriksen S, Linneberg A. The association of ADH and ALDH gene variants with alcohol drinking habits and cardiovascular disease risk factors. Alcohol Clin Exp Res. 2008;32(11):1984–91.
Linneberg A, Gonzalez-Quintela A, Vidal C, Jorgensen T, Fenger M, Hansen T, et al. Genetic determinants of both ethanol and acetaldehyde metabolism influence alcohol hypersensitivity and drinking behaviour among Scandinavians. Clin Exp Allergy. 2010;40(1):123–30.
Steinmetz CG, Xie P, Weiner H, Hurley TD. Structure of mitochondrial aldehyde dehydrogenase: the genetic component of ethanol aversion. Structure. 1997;5(5):701–11.
Liu ZJ, Sun YJ, Rose J, Chung YJ, Hsiao CD, Chang WR, et al. The first structure of an aldehyde dehydrogenase reveals novel interactions between NAD and the Rossmann fold. Nat Struct Biol. 1997;4(4):317–26.
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The protein data bank. Nucleic Acids Res. 2000;28(1):235–42.
Perez-Miller SJ, Hurley TD. Coenzyme isomerization is integral to catalysis in aldehyde dehydrogenase. Biochemistry. 2003;42(23):7100–9.
Moore SA, Baker HM, Blythe TJ, Kitson KE, Kitson TM, Baker EN. Sheep liver cytosolic aldehyde dehydrogenase: the structure reveals the basis for the retinal specificity of class 1 aldehyde dehydrogenases. Structure. 1998;6(12):1541–51.
Notredame C, Higgins DG, Heringa J. T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol. 2000;302(1):205–17.
Webb B, Sali A. Protein structure modeling with MODELLER. Methods Mol Biol. 2014;1137:1–15.
Phillips JC, Braun R, Wang W, Gumbart J, Tajkhorshid E, Villa E, et al. Scalable molecular dynamics with NAMD. J Comput Chem. 2005;26(16):1781–802.
Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 2010;31(2):455–61.
Durrant JD, McCammon JA. BINANA: a novel algorithm for ligand-binding characterization. J Mol Graph Model. 2011;29(6):888–93.
McClean SW, Ruddel ME, Gross EG, DeGiovanna JJ, Peck GL. Liquid-chromatographic assay for retinol (vitamin A) and retinol analogs in therapeutic trials. Clin Chem. 1982;28(4 Pt 1):693–6.
Ongoing and future developments at the Universal Protein Resource. Nucleic Acids Res. 2011;39(Database issue):D214-9.
Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM, et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 2001;29(1):308–11.
Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, et al. GeneCards Version 3: the human gene integrator. Database (Oxford). 2010;2010:baq020.
Lassen N, Estey T, Tanguay RL, Pappa A, Reimers MJ, Vasiliou V. Molecular cloning, baculovirus expression, and tissue distribution of the zebrafish aldehyde dehydrogenase 2. Drug Metab Dispos. 2005;33(5):649–56.
Yoval-Sanchez B, Rodriguez-Zavala JS. Differences in susceptibility to inactivation of human aldehyde dehydrogenases by lipid peroxidation byproducts. Chem Res Toxicol. 2012;25(3):722–9.
Li Y, Zhang D, Jin W, Shao C, Yan P, Xu C, et al. Mitochondrial aldehyde dehydrogenase-2 (ALDH2) Glu504Lys polymorphism contributes to the variation in efficacy of sublingual nitroglycerin. J Clin Invest. 2006;116(2):506–11.
Wang MF, Han CL, Yin SJ. Substrate specificity of human and yeast aldehyde dehydrogenases. Chem Biol Interact. 2009;178(1–3):36–9.
Laskowski RA, Swindells MB. LigPlot+: multiple ligand-protein interaction diagrams for drug discovery. J Chem Inf Model. 2011;51(10):2778–86.
Shen MY, Sali A. Statistical potential for assessment and prediction of protein structures. Protein Sci. 2006;15(11):2507–24.
Lee KH, Kim HS, Jeong HS, Lee YS. Chaperonin GroESL mediates the protein folding of human liver mitochondrial aldehyde dehydrogenase in Escherichia coli. Biochem Biophys Res Commun. 2002;298(2):216–24.
Sydow K, Daiber A, Oelze M, Chen Z, August M, Wendt M, et al. Central role of mitochondrial aldehyde dehydrogenase and reactive oxygen species in nitroglycerin tolerance and cross-tolerance. J Clin Invest. 2004;113(3):482–9.
Chen Z, Stamler JS. Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase. Trends Cardiovasc Med. 2006;16(8):259–65.
Beretta M, Gorren AC, Wenzl MV, Weis R, Russwurm M, Koesling D, et al. Characterization of the East Asian variant of aldehyde dehydrogenase-2: bioactivation of nitroglycerin and effects of Alda-1. J Biol Chem. 2010;285(2):943–52.
Bchini R, Vasiliou V, Branlant G, Talfournier F, Rahuel-Clermont S. Retinoic acid biosynthesis catalyzed by retinal dehydrogenases relies on a rate-limiting conformational transition associated with substrate recognition. Chem Biol Interact. 2013;202(1–3):78–84.
Chen Y, Orlicky DJ, Matsumoto A, Singh S, Thompson DC, Vasiliou V. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer. Biochem Biophys Res Commun. 2011;405(2):173–9.
Way MJ. Computational modelling of ALDH1B1 tetramer formation and the effect of coding variants. Chem Biol Interact. 2014;207:23.
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248–9.
Larson HN, Weiner H, Hurley TD. Disruption of the coenzyme binding site and dimer interface revealed in the crystal structure of mitochondrial aldehyde dehydrogenase “Asian” variant. J Biol Chem. 2005;280(34):30550–6.
Larson HN, Zhou J, Chen Z, Stamler JS, Weiner H, Hurley TD. Structural and functional consequences of coenzyme binding to the inactive asian variant of mitochondrial aldehyde dehydrogenase: roles of residues 475 and 487. J Biol Chem. 2007;282(17):12940–50.
Oze I, Matsuo K, Hosono S, Ito H, Kawase T, Watanabe M, et al. Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese population. Cancer Sci. 2010;101(8):1875–80.
Yokoyama A, Muramatsu T, Omori T, Yokoyama T, Matsushita S, Higuchi S, et al. Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis. 2001;22(3):433–9.
Muto M, Hitomi Y, Ohtsu A, Ebihara S, Yoshida S, Esumi H. Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut. 2000;47(2):256–61.
Jo SA, Kim EK, Park MH, Han C, Park HY, Jang Y, et al. A Glu487Lys polymorphism in the gene for mitochondrial aldehyde dehydrogenase 2 is associated with myocardial infarction in elderly Korean men. Clin Chim Acta. 2007;382(1–2):43–7.
Deak KL, Dickerson ME, Linney E, Enterline DS, George TM, Melvin EC, et al. Analysis of ALDH1A2, CYP26A1, CYP26B1, CRABP1, and CRABP2 in human neural tube defects suggests a possible association with alleles in ALDH1A2. Birth Defects Res A Clin Mol Teratol. 2005;73(11):868–75.
Akaboshi S, Hogema BM, Novelletto A, Malaspina P, Salomons GS, Maropoulos GD, et al. Mutational spectrum of the succinate semialdehyde dehydrogenase (ALDH5A1) gene and functional analysis of 27 novel disease-causing mutations in patients with SSADH deficiency. Hum Mutat. 2003;22(6):442–50.
Chambliss KL, Gray RG, Rylance G, Pollitt RJ, Gibson KM. Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J Inherit Metab Dis. 2000;23(5):497–504.
Rizzo WB, Carney G. Sjogren-Larsson syndrome: diversity of mutations and polymorphisms in the fatty aldehyde dehydrogenase gene (ALDH3A2). Hum Mutat. 2005;26(1):1–10.
Palo OM, Soronen P, Silander K, Varilo T, Tuononen K, Kieseppa T, et al. Identification of susceptibility loci at 7q31 and 9p13 for bipolar disorder in an isolated population. Am J Med Genet B Neuropsychiatr Genet. 2010;153B(3):723–35.
Xiao Q, Weiner H, Crabb DW. The mutation in the mitochondrial aldehyde dehydrogenase (ALDH2) gene responsible for alcohol-induced flushing increases turnover of the enzyme tetramers in a dominant fashion. J Clin Invest. 1996;98(9):2027–32.
ACKNOWLEDGMENTS AND DISCLOSURES
The authors wish to thank the Computational Chemistry and Biology Core Facility at the University of Colorado Anschutz Medical Campus for their contributions to these studies. The authors wish to thank the laboratory of Dr. Tom Hurley (Indiana University, Indianapolis, IN) for providing the modified ALDH1B1 plasmid and for a critical reading of the manuscript. The Protein Production / Tissue Culture / MoAB Shared Resource at the University of Colorado Cancer Center provided expression of ALDH1B1 in eukaryotic cells, and is supported by the Cancer Center Support Grant (P30CA046934). This work was supported, in part, by the following NIH Grants—EY11490, AA021724, and AA022057. Fellowship support to B.C.J. (F31 AA020728) is also acknowledged.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Figure S1
Amino acid alignment of ALDH1B1 and ALDH2. An alignment was generated by T-COFFEE (23). Amino acids are classified as identical (*), highly similar (:), somewhat similar (.), or dissimilar ( ). Secondary structures are labeled by homology with ALDH2 with beta pleated sheets tinted blue and alpha helices tinted green. ALDH1B1 polymorphic variants are indicated by arrows and labeled as *2, *3, and *5. (PDF 54 kb)
Figure S2
Representative three dimensional docking poses for substrates of ALDH1B1. Amino acids of ALDH1B1 that make hydrogen bonds to the substrate are displayed as ball-and-stick figures and are labeled. Substrates are shown as stick figures (non-polar hydrogen atoms and bond order are not shown). Hydrogen bonds are shown as dashed green lines. (PDF 374 kb)
Figure S3
Scoring functions for ALDH1B1 wild type and variant homology models. Initial models were ranked by DOPE score, an unnormalized score with an arbitrary scale designed for choosing the most native-like model from multiple homology models (37). Also shown is the Z-score, a normalized DOPE score in which scores >0 indicate relatively poor models, and scores < −1 are considered more ‘native-like’. The minimization energy of the final minimized homology model is also shown. Positive numbers or large differences in this score between models might indicate some major defect in protein structure. (PDF 20 kb)
Figure S4
(PPTX 2.14 mb)
Rights and permissions
About this article
Cite this article
Jackson, B.C., Reigan, P., Miller, B. et al. Human ALDH1B1 Polymorphisms may Affect the Metabolism of Acetaldehyde and All-trans retinaldehyde—In Vitro Studies and Computational Modeling. Pharm Res 32, 1648–1662 (2015). https://doi.org/10.1007/s11095-014-1564-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-014-1564-3